In vivo autoradiographic studies have shown that neurons in the estrogen receptor-␣ knockout (ERKO) mouse brain are capable of concentrating radiolabeled estrogen. In one region of the ERKO hypothalamus that binds estrogen, the preoptic area, we have also shown that a variety of estrogenic compounds modulate the expression of progesterone receptor. Recently, a second estrogen receptor (ER-␤) was isolated from the rat prostate. In situ hybridization studies have demonstrated that ER-␤ mRNA is present in the rat brain as well as the preoptic area of the ERKO mouse brain. Interestingly, ER-␤ mRNA was also detected in regions of the brain where the classical ER is sparse or absent, including the cerebral cortex and hippocampus. Together, the results of these studies suggest the presence and functionality of a nonclassical estrogen receptor in the ERKO brain and provided evidence that this receptor may be ER-␤. Moreover, the localization of ER-␤ mRNA in many new brain regions, including those associated with learning and memory, may provide new insight about the anatomical substrate for estrogen action in the brain.
Estrogen has a profound effect on the developing and adult mammalian brain. In the developing brain, estrogen action has been shown to promote neuronal differentiation and is thought to establish a sex dimorphism in the 'wiring' of certain neuronal pathways. The differential action of estrogen on the brain determines the phenotype of adult brain function, including the pattern of gonadotropin release, proceptive and receptive behavior and other aspects of procreation. It is generally accepted that estrogen regulates these physiological events by binding to its nuclear estrogen receptor (ER), interacting with a specific DNA response element and thereby modulating the expression of certain genes. Through the use of a variety of histochemical techniques, [1] [2] [3] [4] ER has been detected in anatomically distinct regions of the brain, areas where estrogen has been shown to modulate events essential for procreation. Studies with a transgenic mouse which lacks a functional ER have verified the importance of ER in procreation, since ER knockout (ERKO) mice are infertile, probably due to deficits in reproductive behavior and an abnormal estrous cycle. 5 Interestingly, in vitro ligand-binding studies detected a 5-10% residual estrogen binding in the ERKO uterus. 5 This observation and the finding that several neutrotransmitter systems, thought to be profoundly regulated by estrogen, were not dramatically attenuated in the ERKO hypothalamus ( observations), suggested that some genes that are regulated by estrogen in the wild-type animal were still sensitive to changes in estrogen in the ERKO mouse brain.
In order to characterize the residual estrogen activity seen in the ERKO mouse brain, we used high resolution steroid autoradiography 6 with an iodinated estrogen ( 125 I-estrogen) to assess the presence and distribution of estrogen-binding sites. This technique was selected because it allowed us to detect any estrogenbinding site, including ER, splicing variants of ER or unknown estrogen receptors, while techniques such as in situ hybridization and immunocytochemistry were limited to evaluating known mRNAs or proteins. In these studies, ERKO and wild-type mice were ovariectomized and injected with 125 I-estrogen and the brains processed for steroid autoradiography. Evaluation of brain sections revealed cells in the ERKO mouse brain capable of concentrating 125 I-estrogen. 7 The estrogenbinding cells were seen in a number of brain regions including the medial preoptic area (Figure 1a ), arcuate nucleus, bed nucleus of the stria terminalis and amygdala. 7 Although the number of labeled cells and intensity of nuclear concentration of the 125 I-estrogen was attenuated in the ERKO mouse brain when compared with wild-type littermates, these initial studies revealed the presence of a nuclear binding site in the ER disrupted mouse brain. 7 Previous studies from our laboratory have shown that the expression of progesterone receptor (PR) mRNA in the rat preoptic area was markedly enhanced by a small dose of 17␤-estradiol. 8 Since residual estrogen binding was detected in the ERKO preoptic area ( Figure 1a) , we evaluated the expression of PR mRNA in this region of the ERKO mouse brain using in situ hybridization histochemistry. Initial studies with ERKO animals revealed that the level of PR mRNA in the ERKO preoptic area was attenuated when compared with wild-type littermates, 7 but higher than expected considering these animals were thought not to have an ER. Additional studies showed that when ERKO or wild-type mice were ovariectomized, the level of PR mRNA was significantly reduced, while treatment of ovariectomized animals with 17␤-estradiol or other estrogens markedly enhanced PR expression to a level comparable to that seen in the intact ERKO brain 7 (Figure 1b) . Similarly, immunocytochemical studies have also detected PR in the ERKO preoptic area and shown that the level of PR changed with animal ovariectomy and subsequent treatment with estrogen. 9 The results of these studies demonstrated that the expression of PR mRNA and protein was still modulated by estrogens in the ERKO preoptic area. In the absence of a classical ER, the results of binding studies and the regulation of PR by estrogen suggested the presence and functionality of a nonclassical estrogen receptor.
At the same time that we obtained the results from these ERKO studies, a novel member of the steroid receptor superfamily was isolated from the rat prostate. 10 This new receptor, denoted ER-␤, has a high degree of sequence homology with the classical ER (ER-␣), exhibits a specific binding affinity for estradiol and is capable of activating the transcription of an estrogen response element reporter gene construct. 10 Initial in situ hybridization histochemistry studies showed that ER-␤ mRNA was abundant in the epithelial cells of the prostate and granulosa cells of ovarian follicles, but sparse or absent in the rat uterus, a pattern of distribution that was clearly different from ER-␣ mRNA. 10 Based on these observations, we were interested to see if ER-␤ mRNA was expressed in the brain and if so if it matched the pattern of residual binding seen in the ERKO mouse brain. Our first studies evaluated the distribution of ER-␤ mRNA in the rat hypothalamus, 11 with a subsequent study comparing the distribution of ER-␣ and ER-␤ mRNA in the rat CNS 12 ( Figure 2 ). The results of these studies revealed an extensive presence of ER-␣ and ER-␤ mRNA throughout the rat brain and spinal cord. Many regions contained both receptors including the preoptic area of the hypothalamus 11, 12 (Figure 2a and b) . In addition, certain neuronal populations expressed either ER-␣ or ER-␤ mRNA alone (compare Figure 2a vs b, c vs d, e vs  f) . Neurons of the olfactory bulb, cerebral cortex (Figure 2f and h) , hippocampus (Figure 2d and f) , cerebellum, and the supraoptic (Figure 2b ) and paraventricular nuclei (Figure 2d ) of the hypothalamus contained exclusively ER-␤ mRNA. 11, 12 In contrast, only ER-␣ hybridization signal was prominent in the ventromedial hypothalamic nucleus 11, 12 (Figure 2e ), an area that is critical for hormonal regulation of reproduction. These results demonstrated that ER-␤ mRNA was expressed in the rat brain and that it was present in regions where residual estrogen binding was seen in the ERKO brain. However, since ER-␣ could be important in the expression of ER-␤, or the development of the neurons that express ER-␤, studies were conducted to determine whether ER-␤ mRNA was expressed in the wildtype and ERKO mouse brain. The results of these studies demonstrated that ER-␤ mRNA was expressed in Figure 2 Representative autoradiograms of ER-␣ (a, c, e and g) and ER-␤ (b, d, f and h) mRNA-containing cells in the rat brain by in situ hybridization histochemistry. Note the differences between the distribution of ER-␣ and ER-␤ mRNA in adjacent sections (a vs b, c vs d, e vs f) from the brain at the level of the hypothalamus. While ER-␣ mRNA is abundant in the arcuate nucleus (Arc) and ventromedial hypothalamic nucleus (Vmh), it is sparse or absent in many regions that contain ER-␤ mRNA including the supraoptic nucleus (SON), paraventricular nucleus (PVN), hippocampus (HIP) and cerebral cortex. In contrast, both ER receptor mRNAs are present in the preoptic area (POA), bed nucleus of the stria terminalis (BNST) and medial amygdala (MeA). High power photomicroscopic images clearly show the marked difference between the expression of ER-␣(g) and ER-␤(h) mRNA in neurons of the cerebral cortex as indicated by the number of silver grains over cells (arrowheads).
the ERKO mouse brain and that the topographical distribution was comparable to that seen in wild-type mice and similar to the rat brain. 13 In particular, ER-␤ mRNA was seen in the region of preoptic area where residual binding of 125 I-estrogen was seen and where estrogen modulated the expression of PR mRNA.
Together, the results of these studies have suggested the presence and functionality of a non-classical estro-gen receptor in the ERKO brain and provided anatomical evidence that this receptor may be ER-␤. It is, however, interesting to note that the 125 I-estrogen binding is very weak considering the similar levels of ER-␤ mRNA in ERKO and wild-type mice. 13 In addition, the regulation of PR mRNA by 17␤-estradiol is much greater than expected, based on the binding seen in the preoptic area. This suggests that the marked reduction in labeling seen in the ERKO mouse brain may be due to the weak affinity of 125 I-estrogen for ER-␤ or that residual binding is due to a splicing variant of ER-␣.
The discovery of a new receptor for estrogen may help to explain how estrogen modulates many important neuronal functions including those associated with learning and memory. The role of estrogen in cognition is supported by recent observations that estrogen replacement therapy improves cognitive functions in postmenopausal women. 14, 15 Until the discovery of ER-␤ and its localization in regions associated with learning and memory (cerebral cortex and hippocampus), these data were difficult to explain since little or no ER-␣ is present in these regions. Data from the rat and mouse brain suggest that ER-␤ may be the receptor through which estrogen mediates its effects on these functions. Interestingly, the extremely low number of neurons expressing ER-␤ mRNA in the ventromedial hypothalamic nucleus and the low level of expression in the arcuate nucleus, suggests that ER-␤, unlike ER-␣, may play only a limited role in the central regulation of procreation. Thus, the differential distribution of the ERs in the brain may provide a substrate for the selective modulation of physiological parameters involved with reproduction as well as the regulation of non-reproductive events such as learning and memory. Future studies are clearly needed to demonstrate that ER-␤ mRNA is translated into protein and that estrogen action through ER-␤ activates neuronal systems that are different from those activated through ER-␣.
